Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

9.17
Delayed Data
As of Jun 24
 -0.68 / -6.90%
Today’s Change
4.50
Today|||52-Week Range
11.69
+36.46%
Year-to-Date
The Brexit Vote Is Crushing These 3 Clinical-Stage Biotech Stocks
Jun 24 / MotleyFool.com - Paid Partner Content
Inovio Pharmaceuticals (INO) Optimistic on Zika/Ebola Vaccine Progress
Jun 21 / TheStreet.com - Paid Partner Content
Inovio Pharmaceuticals (INO) Highlighted As Weak On High Volume
Jun 22 / TheStreet.com - Paid Partner Content
Inovio Pharmaceuticals (INO) Is Today's Strong On High Volume Stock
Jun 21 / TheStreet.com - Paid Partner Content
Zika vaccine maker's stock is on fire
Jun 22 / CNNMoney.com
How Inovio Pharmaceuticals Is Leading the Zika Vaccine Race
Jun 21 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: Be Patient on Alcoa
Jun 22 / TheStreet.com - Paid Partner Content
Better Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc.
Jun 16 / MotleyFool.com - Paid Partner Content
Inovio Stock Up, Zika Vaccine Gets Nod for Phase I Study
Jun 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close9.85
Today’s open9.11
Day’s range9.03 - 9.49
Volume2,744,479
Average volume (3 months)1,736,707
Market cap$672.6M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-1.15-6.98%
RTRXRetrophin Inc-0.69-3.73%
FMIFoundation Medicine ...-1.14-5.87%
ANIPANI Pharmaceuticals ...-1.93-3.43%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts

Partner Offers

Search for Jobs